Analysis of genomic and metabolic data in newborns with genetic diseases

Multicenter Analysis of Genomic and Metabolic Data of Neonatal Genetic Diseases

Sixth Affiliated Hospital, Sun Yat-sen University · NCT06183138

This study is trying to see if analyzing genetic and metabolic information from newborns can help doctors better diagnose genetic diseases.

Quick facts

Study typeObservational
Enrollment40000 (estimated)
Ages1 Day to 28 Days
SexAll
SponsorSixth Affiliated Hospital, Sun Yat-sen University (other)
Locations1 site (Guangzhou, Guangdong)
Trial IDNCT06183138 on ClinicalTrials.gov

What this trial studies

This observational study collects and analyzes genomic sequencing and metabolomics data from approximately 40,000 newborns to construct a comprehensive database of neonatal genetic diseases. The research aims to utilize machine learning algorithms to develop predictive models for diagnosing common genetic diseases based on this data. By examining the correlation between genetic variations and metabolic profiles, the study seeks to enhance the accuracy of disease detection and expand the application of tandem mass spectrometry technology. The data collection spans from January 2019 to August 2022 across multiple centers in South China.

Who should consider this trial

Good fit: Ideal candidates for this study are newborns aged 1 to 28 days with a gestational age of 37 to 42 weeks.

Not a fit: Patients with unclear clinical information or data that cannot be analyzed will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to more accurate and timely diagnoses of genetic diseases in newborns, improving early intervention and treatment outcomes.

How similar studies have performed: Other studies utilizing genomic and metabolomic data for disease prediction have shown promise, indicating that this approach is both relevant and potentially impactful.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 1-28 days
* gestational age 37-42 weeks

Exclusion Criteria:

* Neonatal data with unclear clinical basic information
* Lack of traceability core information data
* The data that the test results cannot be analyzed and interpreted

Where this trial is running

Guangzhou, Guangdong

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Hereditary Diseases, neonatal genetic diseases, Defect, Newborn

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.